Skip to Content

125/DPI (Estropipate 1.5 mg)

Pill with imprint 125/DPI is , and has been identified as Estropipate 1.5 mg. It is supplied by Watson Pharmaceuticals.

Estropipate is used in the treatment of postmenopausal symptoms; atrophic urethritis; atrophic vaginitis; hypoestrogenism; oophorectomy (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 125/DPI

Estropipate

Imprint:
125/DPI
Strength:
1.5 mg
Availability:
Prescription only
Drug Class:
Estrogens
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
National Drug Code (NDC):
00364-2601

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide